John Brendan Doyle Cognition Therapeutics Inc (CGTX) insider trading activity

CGTX Quotes by TradingView

John Brendan Doyle is Chief Financial Officer of COGNITION THERAPEUTICS INC. Currently has a direct ownership of 414,402 shares of CGTX, which is worth approximately $186,480. The most recent transaction as insider was on Feb 15, 2025, when has been sold 1,723 shares (Common Stock) at a price of $0.59 per share, resulting in proceeds of $1,016. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 414K
242.13% 3M change
219.2% 12M change
Total Value Held $186,480

John Brendan Doyle Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 15 2025
SELL
Payment of exercise price or tax liability
$1,016 $0.59 p/Share
1,723 Reduced 0.41%
414,402 Common Stock
Feb 04 2025
BUY
Grant, award, or other acquisition
-
295,000 Added 41.48%
416,125 Common Stock
May 01 2024
SELL
Payment of exercise price or tax liability
$16,963 $1.95 p/Share
8,699 Reduced 6.7%
121,125 Common Stock
Feb 15 2024
BUY
Grant, award, or other acquisition
-
20,000 Added 13.35%
129,824 Common Stock
May 01 2023
BUY
Grant, award, or other acquisition
-
109,824 Added 50.0%
109,824 Common Stock
JBD

John Brendan Doyle

Chief Financial Officer
Purchase, NY

Track Institutional and Insider Activities on CGTX

Follow COGNITION THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CGTX shares.

Notify only if

Insider Trading

Get notified when an Cognition Therapeutics Inc insider buys or sells CGTX shares.

Notify only if

News

Receive news related to COGNITION THERAPEUTICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CGTX